Blog

by Heidi Hagen and Christophe Suchet | April 2, 2020
The COVID-19 pandemic presents all of us with a dynamic, disruptive challenge unlike anything most of us have experienced in our lifetime. As we publish this post, we very much hope that all of you are safe and healthy.

by Vineti | March 9, 2020
Vineti is thrilled to announce that Phil Calvin has joined Vineti as our Chief Technology Officer. A veteran technology executive at Salesforce, other SaaS innovation companies, and his own start-ups, Phil brings more than 25 years of software…

by Amy DuRoss | March 2, 2020
At our core, Vineti is a technology company focused on health, well-being, and patient safety. Our software platform manages critical CAR-T cell therapies and other personalized therapeutics on behalf of patients daily. That mission-critical work…

by Amy DuRoss and Heidi Hagen | February 5, 2020
On February 5th, 2020, we announced Vineti’s $35 million Series C round of investment. A first-of-its-kind investor coalition of industry leaders -- Cardinal Health, Novartis Pharma AG, and Kite, a Gilead Company -- came together with our current…

by Amy DuRoss | January 15, 2020
Vineti, Inc., the provider of the leading digital platform of record for personalized therapeutics, today announced the appointment of John Kontor, M.D. to the company’s Board of Directors. Dr. Kontor, a clinical leader with deep experience in both…

Subscribe to our blog
Required
Required
Required
Required
Required
Required
Required